Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity

K J Klos1, J E Ahlskog, N Kumar

  • 1Department of Neurology, Mayo Clinic, Rochester, MN, USA. kklos@tulsacoxmail.com

Neurology
|December 13, 2006
PubMed
Abstract

Insights

In chronic liver failure, manganese accumulation causes pallidal MRI T1 hyperintensity and neurological issues like parkinsonism. This T1 hyperintensity serves as a biomarker for manganese overload.

Area of Science:

  • Neuroimaging
  • Neuropathology
  • Toxicology

Background:

  • Chronic liver failure can lead to neurological syndromes, including parkinsonism and cognitive impairment.
  • Associated MRI findings include pallidal T1 hyperintensity, potentially linked to manganese accumulation.

Purpose of the Study:

  • Quantify manganese and other metal concentrations in the basal ganglia and other brain regions in chronic liver failure.
  • Correlate metal levels with neuropathological findings, specifically Alzheimer type II gliosis and alpha-synuclein/tau pathology.

Main Methods:

  • Metal concentrations in brain tissue were measured using ICP-MS in seven chronic liver failure patients and five controls.
  • Neuropathological analysis involved immunohistochemistry for alpha-synuclein and tau proteins.

Main Results:

  • Significantly elevated manganese levels were found in the pallidum and other brain regions of patients with chronic liver failure, especially those with T1 hyperintensity.
  • Copper levels were also increased in affected brain regions, but manganese accumulation was the primary driver of T1 hyperintensity.
  • Mild to moderate Alzheimer type II gliosis was observed, with minimal alpha-synuclein or tau staining.

Conclusions:

  • Manganese accumulation is the cause of pallidal MRI T1 hyperintensity in chronic liver failure.
  • Pallidal T1 hyperintensity is a reliable biomarker for manganese overload.
  • Basal ganglia metal accumulation, particularly manganese, may underlie parkinsonism in chronic liver failure.